Demand for Portable Intravenous Solutions Surging Amid Increasing Focus on Improved Patient Care: Fact.MR

Rising incidence of cancer and diabetes to increase the sales of intravenous solutions

As per a study by Fact.MR, the global intravenous solutions market is estimated to demonstrate a healthy growth for the forecast period 2021 to 2031.

Rising prevalence of diseases such as neurological diseases, cancer, diabetes, and gastrointestinal disorder are the key factors driving the growth of the intravenous solutions market.

According to the Centers for Disease Control and Prevention (CDC), around 34.2 million people were suffering from diabetes in 2020 in the U.S., which is nearly 10.5% of the U.S. total population. Diabetes might cause malnourishment in aged patient. In that event, intravenous solution emerges as a viable solution. Thus, rising prevalence of diabetes will in turn fuel the demand for intravenous solutions in the market.

According to the most recent estimate by the American Cancer Society, around 12,620 new incidences of laryngeal cancer will be reported and nearly 3,770 people will die from laryngeal cancer in the U.S., in 2021.

Patients suffering from these types of cancers are thoroughly dependent on intravenous solutions because of difficulty in eating. This will emerge as a chief driver for the intravenous solutions market growth.

The COVID-19 outbreak has surged the demand for intravenous solutions. The World Health Organization (WHO) has recommended that coronavirus patients with respiratory failure should be treated with intravenous fluids. This has boosted the sales of intravenous solutions across the globe.

For more insights into the Market, Request a Brochure

“To expand their portfolio and market share, leading manufacturers are coming up with new innovative products such as portable and premixed intravenous solutions to increase convenience and reduce the packaging waste,” says the Fact.MR analyst.

Key Takeaways

  • The U.S. accounts for the largest market share of intravenous solutions due to the high rate of consumption and presence of key players.
  • High prevalence of novel coronavirus is creating significant demand for intravenous solutions in the U.K.
  • Asia Pacific is expected to emerge as the fastest-growing region owing to increasing focus on healthcare infrastructure.
  • The demand for intravenous solutions is steadily increasing due to the high prevalence of premature birth.
  • The Total Parenteral Nutrition (TPN) segment is leading the market with the largest revenue share.

Key Drivers

  • Rising incidence of cancer is boosting the demand for intravenous solutions.
  • The coronavirus pandemic is spurring the sales of intravenous solutions.
  • Increasing investment in healthcare infrastructure is expected to drive market growth.
  • Product innovations by key manufacturers will surge the demand for intravenous solutions.

Key Restraints

  • Unavailability of intravenous solutions due to limited suppliers are restraining the market growth in certain countries.
  • Lack of precision and skills are the key factors affecting the demand for intravenous solutions, negatively.

Explore tables and figures of the study. Request ToC of the report at

Competitive Landscape

Leading manufacturers and suppliers of the intravenous solutions market profiled by Fact.MR includes include B. Braun Melsungen AG, icumedical Inc., Otsuka Group, Baxter, Grifols S.A, Pfizer Inc., Claris Lifesciences Ltd., Fresenius SE & Co. KGaA, Eurolife Healthcare, and Sichuan Kelun Pharmaceutical Co. Ltd. Some of the leading manufacturers are focusing on the mergers & acquisitions to expand their regional presence. For instance,

  • Eurolife announced the acquisition of Teva Pharmaceutical Industries, an intravenous (IV) infusion business in December 2019. The acquisition was executed to expand company’s global presence.
  • In 2019, B. Braun Medical Inc. announced an investment of $1 billion in novel intravenous solutions therapy manufacturing facilities.

More Insights on the Intravenous Solutions Market

Fact.MR offers unbiased analysis of the intravenous solutions market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis solution type (crystalloids and colloids), nutrition type (total parenteral nutrition, and peripheral parenteral nutrition), and end user (hospitals, clinics, ambulatory surgical centers, homecare settings, and others), across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Rare Neurological Disease Treatment Market - The global market for rare neurological disease treatments is likely to be highly concentrated. Manufacturers are concentrating their efforts on finding novel remedies to reduce the burden of uncommon diseases, hence boosting their market share. Furthermore, in order to capture a larger share of the global market, innovations across the value chain and medication delivery approaches are expected to be critical.

Diabetes Diagnostics Market - The demand for diabetes diagnostics is predicted to increase as a result of the COVID-19 outbreak, which has resulted in an increase in hospitalizations. Diabetes test strips are in high demand as a result of studies that show diabetics are at a higher risk of becoming seriously ill if infected with the virus. In a recent analysis by Fact.MR predicted that hospital demand will continue to rise over the prediction period of 2020 to 2030.

Intravenous Transportation System Market - One of the primary factors driving the Intravenous Transportation System market is the increase in the ageing population and rising chronic diseases, which is one of the major factors driving the market. The market for Intravenous Transportation System is also growing as technological developments reduce mobility concerns. The Intravenous Transportation System was created by integrating the benefits of bed-mounted and stand-alone intravenous poles into one product.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter
Source: Fact.MR

Back to news